⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Beta Drugs Limited and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Beta Drugs Limited
↗Panchkula, India
Beta Drugs Limited is an India-based pharmaceutical company specializing in the development, manufacturing, and sale of oncology products and cosmeceuticals. A key entity within the Adley Group, the company provides a wide range of oncology formulations, including liquid and lyophilized injections, tablets, and capsules, and is recognized as a significant player in the Indian cytotoxic drug market.
The company maintains a strong focus on R&D, including Novel Drug Delivery Systems (NDDS) and first-to-market generic oncology products. It operates as both a branded formulation provider and a CRAM (Contract Research and Manufacturing) partner for over 50 pharmaceutical firms, with a growing international presence across more than 20 countries.
CLASSIFICATION
SIZE & FINANCIALS
Employees:201-500
Revenue:₹396 Cr (FY2026)
Founded:2005
Ownership:public
Status:operating
STOCK
Exchange:NSE
Ticker:BTAD
Market Cap:₹1.49B
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Injectables
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Adley Group
Subsidiaries:Nivian Lifesciences
Key Partnerships:Serves as a CRAM partner for over 50 Indian pharmaceutical companies.
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Rahul Batra - Chairperson & Managing Director
Varun Batra - Joint Managing Director
Ashutosh Shukla - Whole Time Director
Scientific Founders:Vijay Batra
Board Members:Rahul Batra, Varun Batra, Ashutosh Shukla, Balwant Singh, Ajay Mahipal
LINKS
Website:betadrugslimited.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Beta Drugs Limited. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.